BridgeMD
New treatment option for Stroke Acute
Official title One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy
ClinicalTrials.gov ID: NCT07052045
What this study is testing
- What it's testing
- Stroke, especially acute ischemic stroke (AIS) caused by a blocked blood vessel in the brain, is a leading cause of death and long-term disability. When the blockage is in a large blood vessel, a procedure called endovascular therapy (EVT)-where the clot is removed using a catheter-is highly effective.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Symptoms suggestive of an acute ischemic stroke caused by a large or medium vessel occlusion as defined by a National Institute of Health Stroke...
- Patient presents directly to the treating hospital (mothership patient) within 4.5 hours of last seen well (LSW)
- Age ≥ 18 years
- Patient was independent in daily activities prior to the stroke (pre stroke modified Rankin Scale of 0 - 2)
- Endovascular treatment team available (Neurologist, Interventionist, Anesthesiologist, Nursery, Technicians)
You likely can't join if
- Severe comorbidities, which will likely prevent improvement or follow-up
- In-hospital stroke
- Clinical symptoms suggestive of intracranial hemorrhage (deterioration of patient during transport, vomiting or depressed consciousness)
- Strong suspicion of functional neurological symptom disorder / conversion disorder
- Hemodynamically unstable patients who require advanced vital support
- Angiography room occupied by other procedure
See the full eligibility criteria
- Symptoms suggestive of an acute ischemic stroke caused by a large or medium vessel occlusion as defined by a National Institute of Health Stroke Scale (NIHSS) Score of ≥ 10 points
- Patient presents directly to the treating hospital (mothership patient) within 4.5 hours of last seen well (LSW)
- Age ≥ 18 years
- Patient was independent in daily activities prior to the stroke (pre stroke modified Rankin Scale of 0 - 2)
- Endovascular treatment team available (Neurologist, Interventionist, Anesthesiologist, Nursery, Technicians)
- Informed Consent as documented by signature or fulfilling the criteria for emergency consent procedures
- Severe comorbidities, which will likely prevent improvement or follow-up
- In-hospital stroke
- Clinical symptoms suggestive of intracranial hemorrhage (deterioration of patient during transport, vomiting or depressed consciousness)
- Strong suspicion of functional neurological symptom disorder / conversion disorder
- Hemodynamically unstable patients who require advanced vital support
- Angiography room occupied by other procedure
The study team makes the final eligibility decision.
Where it's taking place
- Nuremberg, Germany
- Basel, Switzerland
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nuremberg, Germany; Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.